6 results about "Rapid onset" patented technology

Provided are methods for treating pemphigus using an FcRn antagonist such as efgartigimod. The methods of the invention provide a rapid onset of action to enable early disease control and maintenance of clinical remission, with or without a minimal dose of corticosteroids.

The invention discloses a traditional Chinese medicine composition for treating hepatitis A as well as a preparation method and application thereof. The traditional Chinese medicine composition is prepared from the following raw materials by weight: 30-80g of fried radix bupleuri, 30-80g of medicated leaven, 100-200g of fresh wild lysimachia christinae hance and 50-80g of honey (used for processing radix bupleuri). The traditional Chinese medicine composition has the technical effect of taking effect quickly, the symptoms are obviously improved, and the traditional Chinese medicine composition takes effect on that day: clinical observation shows that the symptoms such as inappetence, nausea and hypodynamia can be obviously improved within 24 hours after a patient takes the traditional Chinese medicine composition, and the traditional Chinese medicine composition is superior to conventional treatment (generally 2-3 days). The jaundice fading time is averagely 3-5 days and is obviously shortened compared with that of a traditional prescription (7-10 days), and the traditional Chinese medicine is particularly suitable for acute-stage patients.

The invention discloses a cool external spray for relieving muscular pain, and belongs to the technical field of external pain relieving preparations. Every 100g of the spray contains 7.00 g of corydalis tuber oil, 9.00 g of angelica dahurica oil, 12.00 g of menthol, 1.30 g of clove oil, 2.00 g of borneol and the balance of basic carriers such as a solvent, a stabilizer and the like. The preparation process comprises the links of raw material weighing, component dissolving, mixing, filtering, filling and the like. By means of the synergistic effect of various components, the traditional Chinese medicine composition achieves the remarkable pain relieving effect, has the advantages of being cool, comfortable, rapid in effect taking, mild, free of stimulation, convenient to use and the like, and can effectively relieve muscular pain and improve user experience.

Presented herein are powder formulations comprising dihydroergotamine (DHE), or a pharmaceutically acceptable salt thereof. In addition to such formulations, also presented herein are methods comprising intranasally administering powder formulations comprising dihydroergotamine, or a pharmaceutically acceptable salt thereof. The presented methods can be used for treating headache, for example, for rapid onset treatment of headache, including migraine, e.g. acute treatment of migraine with or without aura.

A benzodiazepine compound represented by formula I, or a salt thereof has an intravenous sedative anesthesia effect. The recovery quality of the compound is significantly improved compared with remimazolam in rat and mouse caudal venous anesthesia models. During anesthetization, the compound has a rapid onset, a short duration, a quick recovery and a good tolerance, can be used for anesthesia induction, anesthesia maintenance and day surgery anesthesia.

The application provides a new compound with local anesthesia and general deep sedation function and medical use. The new compound has the structure shown in the following formula: The compound has local anesthesia and also exhibits a unique general sedative effect, suggesting that it has general anesthesia potential, and its rapid onset and recovery characteristics make it possible to be used for developing a new intravenous anesthetic.